Background. The contribution of the hemoglobin concentration to the incidence of hemorrhagic or ischemic stroke in patients undergoing hemodialysis is unclear. Methods. In total, 3436 patients undergoing prevalent hemodialysis were followed up for 4 years. The primary outcome was the first development of hemorrhagic or ischemic stroke. The baseline hemoglobin concentration was divided into quartiles [hemoglobin (g/dL): Q1, 9.7; Q2, 9.8-10.5; Q3, 10.6-11.1; Q4, !11.2]. The association between the hemoglobin concentration and each type of stroke was examined using the KaplanMeier method and a Cox proportional hazards model. Results. During the follow-up period, 76 (2.2%) patients developed hemorrhagic stroke and 139 (4.0%) developed ischemic stroke. The 4-year incidence rate of hemorrhagic stroke was significantly higher in patients with lower hemoglobin concentrations. Compared with the quartile of patients with the highest hemoglobin concentrations (Q4), the multivariable-adjusted hazard ratios for hemorrhagic stroke were 1.18 (95% confidence interval, 0.56-2.51), 1.59 (0.82-3.21) and 2.31 (1.16-4.73) in patients in Q3, Q2 and Q1, respectively. No association was identified between the 4-year incidence rate of ischemic stroke and the hemoglobin concentration. Compared with the quartile of patients with the lowest hemoglobin concentrations (Q1), the multivariable-adjusted hazard ratios for ischemic stroke were 1.17 (95% confidence interval, 0.73-1.89), 0.88 (0.51-1.51) and 1.10 (0.66-1.83) in patients in Q2, Q3 and Q4, respectively. Conclusions. Our results suggest that low hemoglobin concentrations are associated with a high risk of hemorrhagic stroke, but not of ischemic stroke, in patients undergoing hemodialysis.
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I N T R O D U C T I O N
Stroke is a major cause of death and disability in patients undergoing maintenance hemodialysis (HD) [1] [2] [3] . Approximately 7% of deaths in patients undergoing HD in Japan are still caused by stroke despite the fact that these patients have improved longevity and reduced rates of cardiovascular death [3] . Therefore, identifying the risk factors for stroke is urgently needed to facilitate improvements in the prognosis of patients undergoing HD.
A close relationship between high hemoglobin concentrations and the incidence of stroke has been highlighted in the field of chronic kidney disease (CKD), including HD therapy [4] . The Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) was a large-scale randomized controlled trial involving patients with CKD receiving an erythropoiesisstimulating agent (ESA). The TREAT study showed that there was a double risk of stroke in the patient group with higher target hemoglobin concentrations [4] . High hemoglobin concentrations increase blood viscosity and promote thrombosis [5] , which may at least in part explain the association between high hemoglobin concentrations and ischemic stroke. However, the TREAT study did not address the risk of ischemic stroke separate from hemorrhagic stroke.
Low hemoglobin concentrations have also emerged as an established risk factor for the development of cardiovascular disease in the general population [6] and in patients with CKD [7, 8] . The interactions among a poor cardiovascular prognosis, kidney function and anemia form a vicious circle termed cardiorenal anemia syndrome [9] . Observational studies of the general population have shown an association between low hemoglobin concentrations and a high incidence of composite stroke [10, 11] . In this context, the Hisayama study, a prospective population-based cohort survey in Japan, recently showed that low hematocrit levels were associated with a high risk of hemorrhagic stroke in adults in the general population [12] . These findings suggest an association between anemia and hemorrhagic stroke in the real-world setting. However, the contribution of anemia to the incidence of hemorrhagic stroke remains unclear in patients with CKD, including those undergoing HD.
Therefore, the present study was performed to determine the association between the hemoglobin concentration and the risk of hemorrhagic or ischemic stroke separately in a largescale, prospective cohort study of patients undergoing maintenance HD.
M A T E R I A L S A N D M E T H O D S

Study cohort
The Q-Cohort Study was a multicenter, prospective observational study of patients undergoing HD at 39 dialysis facilities in Fukuoka and Saga Prefectures in Kyushu, Japan [13] [14] [15] [16] . A total of 3598 outpatients aged >18 years who underwent prevalent HD participated in the study. All participants were enrolled from December 2006 to December 2007 and followed up until December 2010. Patients without demographic data (n ¼ 65) and patients whose outcomes were missing (n ¼ 97) were excluded. The remaining 3436 patients were analyzed in this study. All patients provided written informed consent. The Q-Cohort Study was approved by the Kyushu University Institutional Review Board for Clinical Research (Approval Number: 20-31) and was registered in the University Hospital Medical Information Network (UMIN) clinical trial registry (UMIN000000556). The study was performed according to the Ethics of Clinical Research (Declaration of Helsinki) requirements.
Definition of outcomes
The primary outcomes were the incidence of first development of hemorrhagic or ischemic stroke. The definitions of each type of stroke were previously published [15] . Briefly, stroke was defined as sudden onset of a neurological deficit persisting for more than 24 h. The types of stroke were determined by the attending physician using imaging of the brain, including computed tomography and magnetic resonance imaging. All events were collected from the paper medical records by the local physician in each dialysis facility. Each of these physicians checked the medical records for the occurrence of specified outcomes and reported them to the steering committee annually. Subarachnoid hemorrhage and hemorrhage after ischemic stroke were excluded from the definition of hemorrhage stroke. During the follow-up period, three patients developed both hemorrhagic and ischemic stroke. They were classified as having developed the first type of stroke and were censored for the subsequent stroke.
Measurement of hemoglobin concentration
For measurement of the baseline hemoglobin concentration, blood samples were collected from a vascular access in the recumbent position before dialysis after a 2-day interdialytic interval. The hemoglobin concentration was measured using standard procedures at multiple facilities depending on the location of each dialysis center.
Measurement of risk factors
Details regarding the measurement of risk factors were previously published [13] [14] [15] [16] . Briefly, demographic data [e.g. age, sex, duration of HD, cause of end-stage kidney disease (diabetic nephropathy or other), history of stroke, use of antihypertensive drugs, use of iron supplementation and dose of ESA] and biochemical parameters [e.g. serum concentrations of albumin, C-reactive protein (CRP), ferritin, total cholesterol and phosphate; Kt/V; systolic blood pressure (BP); body weight; and cardiothoracic ratio (CTR)] were collected at baseline by physicians at each dialysis facility. A history of stroke included hemorrhagic stroke and ischemic stroke. Iron supplementation was provided orally or intravenously. The types of ESAs used in the present cohort were epoetin alfa, epoetin beta and darbepoetin alfa. For darbepoetin alfa, the ESA dose was calculated by multiplying the darbepoetin alfa dose (lg) by 200. Dialysis doses were measured by a single-pool Kt/V method. All available data on BP were measured before dialysis. The CTR was calculated from a chest radiograph in an upright posterioranterior view. The horizontal diameter of the heart was divided by the horizontal inner width of the rib cage.
Statistical analysis
Baseline data according to quartiles (Q) of hemoglobin concentrations are shown as mean 6 standard deviation for normally distributed continuous variables, median (interquartile range) for non-normally distributed continuous variables and number (percentage) for categorical variables. The distribution of baseline data divided by quartiles of hemoglobin concentrations was compared using trend analysis. The incidence rates for hemorrhagic and ischemic stroke according to the hemoglobin concentrations were plotted by the Kaplan-Meier method and compared by the log-rank test. The unadjusted, age-and sex-adjusted, fully adjusted and parsimoniously adjusted hazard ratios with 95% confidence intervals of hemorrhagic and ischemic stroke according to the hemoglobin concentrations were calculated using a Cox proportional hazards model. The assumptions of the proportional hazards were graphically checked using the log cumulative hazard plots for each type of stroke according to the hemoglobin concentrations. Because an association between a low hemoglobin concentration and hemorrhagic stroke was assumed, the highest quartile of hemoglobin concentrations was chosen as the reference for the Cox model of hemorrhagic stroke. Because an association between a high hemoglobin concentration and ischemic stroke was assumed, the lowest quartile of hemoglobin concentrations was chosen as the reference for the Cox model of ischemic stroke. The fully adjusted model was adjusted for age, sex, dialysis duration, cause of end-stage kidney disease, history of stroke, use of antihypertensive drugs, use of iron supplementation, dose of ESA, serum albumin concentration, serum CRP concentration, serum ferritin concentration, serum total cholesterol concentration, serum phosphate concentration, Kt/V, systolic BP, body weight and CTR. Variables in the fully adjusted model were based on a priori clinical judgment and previous studies [5, 11, 12, 15] . Variables in the parsimoniously adjusted model were selected using the Cox proportional hazard model and a stepwise backward method with P < 0.05 for the remaining variables to determine the risk factors for each type of stroke. Continuous multivariable-adjusted associations of the hemoglobin concentrations and hazard ratios with 95% confidence intervals for hemorrhagic and ischemic stroke were plotted using restricted cubic splines. We used four knots located at the 5th, 35th, 65th and 95th percentiles of the hemoglobin concentrations as previously recommended [17] . The multivariableadjusted model was adjusted for the same variables as the fully adjusted Cox model. Age, dialysis duration, dose of ESA, serum albumin concentration, serum CRP concentration, serum ferritin concentration, serum total cholesterol concentration, serum phosphate concentration, Kt/V, systolic BP, body weight and CTR were treated as spline terms. The mean hemoglobin concentration (10.5 g/dL) was chosen as the reference for each spline plot. Heterogeneity in the correlation between subgroups was tested by adding a multiplicative interaction term to the relevant Cox model. In the subgroup analysis, multivariableadjusted hazard ratios with 95% confidence intervals of hemorrhagic and ischemic stroke for every 1 g/dL change in the hemoglobin concentration were calculated. The multivariableadjusted model was adjusted for the same variables as the parsimoniously adjusted Cox model for each type of stroke. Statistical calculations were performed using JMP version 11 for Windows (SAS Institute, Cary, NC, USA), SAS software package version 9.3 (SAS Institute) and R version 3.2.4 (http:// www.r-project.org). A difference was considered significant at P < 0.05.
R E S U L T S Baseline characteristics according to quartiles of hemoglobin concentrations
The baseline characteristics of the patients based on the quartiles of hemoglobin concentrations are shown in Table 1 . Patients with lower hemoglobin concentrations were older, were more frequently female and had a higher frequency of iron supplementation. The ESA dosage, serum CRP level, Kt/V and CTR were higher in patients with lower hemoglobin concentrations. In contrast, the serum albumin level, serum total cholesterol level, serum phosphate level and body weight were lower in patients with lower hemoglobin concentrations.
Association between hemoglobin concentration and risk of hemorrhagic stroke
During a 4-year follow-up period, 76 (2.2%) patients developed hemorrhagic stroke. The incidence rates of hemorrhagic stroke according to the quartiles of hemoglobin concentrations are shown in Figure 1A . The 4-year incidence rate significantly increased with lower hemoglobin concentrations (P ¼ 0.03). Patients with the lowest hemoglobin concentrations (Q1) had a 2.31-fold (95% confidence interval, 1.16-4.73) higher risk of hemorrhagic stroke than those with the highest hemoglobin concentrations (Q4) after adjustment for full variables (Table 2 ). An inverse association between the quartiles of hemoglobin concentrations and the fully adjusted hazard ratio for the incidence of hemorrhagic stroke was also evident (P for trend ¼ 0.01). The parsimonious model selected by the stepwise backward method was adjusted for the sensitivity analysis; this essentially resulted in no changes in the associations. The continuous multivariable-adjusted association between the hemoglobin concentration and the risk of hemorrhagic stroke showed a similar relationship (Figure 2A ). The risk of hemorrhagic stroke tended to be higher with lower hemoglobin concentrations. In the upper range of hemoglobin concentrations, the risk of hemorrhagic stroke was significantly lower than the reference.
Association between hemoglobin concentration and risk of ischemic stroke
During the follow-up period, 139 (4.0%) patients developed ischemic stroke. The incidence rates of ischemic stroke according to the quartiles of hemoglobin concentrations are shown in Figure 1B . There was no difference in the incidence rate of ischemic stroke by each quartile according to the hemoglobin concentration. Compared with Q1, the fully adjusted risks of ischemic stroke were 1.17 (95% confidence interval, 0.73-1.89), 0.88 (0.51-1.51) and 1.10 (0.66-1.83) in patients in Q2, Q3 and Q4, respectively ( Table 3 ). The continuous multivariableadjusted association between the hemoglobin concentration and the risk of ischemic stroke is shown in Figure 2B . There was no statistically significant association.
Subgroup analysis stratified by baseline clinical characteristics
The effect of modification of subgroups stratified by baseline covariates was examined. No significant interaction was observed for any subgroups in relation to the hemoglobin concentrations with the risk of hemorrhagic stroke (Table 4) . However, there was a significant interaction between the hemoglobin concentration and use of antihypertensive drugs (P for interaction ¼ 0.04) in relation to the risk of ischemic stroke (Table 5 ). Higher hemoglobin concentrations were more strongly associated with a risk of ischemic stroke in patients who did not use antihypertensive drugs than in those who did use such drugs.
D I S C U S S I O N
In this cohort of patients undergoing HD, we demonstrated a significant association between lower hemoglobin concentrations and a higher risk of hemorrhagic stroke. In contrast, we did not identify a relationship between the hemoglobin A B FIGURE 1: Incidence rate of (A) hemorrhagic stroke and (B) ischemic stroke according to quartiles of hemoglobin concentrations during the 4-year follow-up. Q, quartile. The fully adjusted model is adjusted for age, sex, dialysis duration, cause of end-stage kidney disease, history of stroke, antihypertensive drug use, iron supplementation use, dose of erythropoiesis-stimulating agent, serum albumin concentration, serum C-reactive protein concentration, serum ferritin concentration, serum total cholesterol concentration, serum phosphate concentration, Kt/V, systolic blood pressure, body weight and cardiothoracic ratio. The parsimoniously adjusted model is adjusted for sex, dose of erythropoiesis-stimulating agent, serum phosphate concentration, Kt/V and systolic blood pressure, which were selected using the Cox proportional hazard model and a stepwise backward method with P < 0.05 for the remaining variables to determine the risk factors for the incidence of hemorrhagic stroke. CI, confidence interval; HR, hazard ratio; Q, quartile.
concentration and the incidence of ischemic stroke. Our results indicate the novel importance of anemia as a potential risk factor for hemorrhagic stroke in patients undergoing dialysis. In the present study, lower hemoglobin concentrations were associated with a higher risk of hemorrhagic stroke. This association remained unchanged after adjustment for potential confounding factors. Several observational studies have shown a relationship between anemia and a higher incidence of composite stroke [10, 11] . However, these studies were not designed to distinguish hemorrhagic stroke and ischemic stroke separately as an outcome. The Hisayama study, a population-based cohort study in Japan, revealed that lower hematocrit levels were associated with a higher risk of hemorrhagic stroke after adjustment for potential confounders in adults in the general population [12] . This study was the first to suggest an association between anemia and hemorrhagic stroke. The authors reported that patients with the lowest hematocrits (hematocrit: male, 44.7%; female, 39.3%) had a 1.91-fold (95% confidence interval, 1.03-3.54) higher risk of hemorrhagic stroke than the reference group (hematocrit: male, 47.1-49.6%; female, 41.7-43.7%) during the 19-year follow-up period. They also reported a linear inverse association between the hematocrit level and the hazard ratio for the incidence of hemorrhagic stroke [12] . Our study showed a similar relationship using the hemoglobin concentration instead of the hematocrit in patients undergoing HD, which is a high-risk population with cardiovascular disease.
Based on our results, we generated the hypothesis that anemia is associated with the development of hemorrhagic stroke. Several possible mechanisms support this hypothesis. First, the combination of CKD and anemia is a high risk factor for cardiovascular disease [7, 8] . This association was recently recognized as cardiorenal anemia syndrome [9] . Patients with CKD are subjected to enhanced oxidative stress [18, 19] . A decrease in the blood hemoglobin concentration worsens tissue damage as a result of decreased oxygen supply [20] . Taken together, these findings suggest that such oxidative stress and hypoxia additively or synergistically exacerbate a greater arteriosclerotic A B FIGURE 2: Multivariable-adjusted restricted cubic spline plots of the hazard ratio for (A) hemorrhagic stroke and (B) ischemic stroke according to hemoglobin concentrations. The solid lines represent the hazard ratio and the dotted lines represent the 95% confidence interval. The horizontal gray lines correspond to the normal reference hazard ratio of 1.0. The value of 10.5 g/dL is the mean hemoglobin concentration and was chosen as the reference. The multivariable-adjusted model is adjusted for age, sex, dialysis duration, cause of end-stage kidney disease, history of stroke, use of antihypertensive drugs, use of iron supplementation, dose of erythropoiesis-stimulating agent, serum albumin concentration, serum C-reactive protein concentration, serum ferritin concentration, serum total cholesterol concentration, serum phosphate concentration, Kt/V, systolic blood pressure, body weight and cardiothoracic ratio. The fully adjusted model is adjusted for age, sex, dialysis duration, cause of end-stage kidney disease, history of stroke, antihypertensive drug use, iron supplementation use, dose of erythropoiesis-stimulating agent, serum albumin concentration, serum C-reactive protein concentration, serum ferritin concentration, serum total cholesterol concentration, serum phosphate concentration, Kt/V, systolic blood pressure, body weight and cardiothoracic ratio. The parsimoniously adjusted model is adjusted for age, cause of end-stage kidney disease, history of stroke and cardiothoracic ratio, which were selected using the Cox proportional hazard model and a stepwise backward method with P < 0.05 for the remaining variables to determine the risk factors for the incidence of ischemic stroke. CI, confidence interval; HR, hazard ratio; Q, quartile.
burden on the cerebral blood vessels. Second, anemia may reflect a decline in the protective role against bleeding played by red blood cells (RBCs). Ameliorating anemia with RBC transfusions shortens the bleeding time in uremic conditions [21, 22] . Moreover, in experimental models, adenosine triphosphate released from RBCs facilitates activation of platelets [23] , and RBCs promote thrombin generation [24, 25] . Therefore, anemia is potentially associated with hemorrhagic stroke through a disorder of the coagulation system. Our subgroup analysis suggested several interesting effect modifiers in relation to the hemoglobin concentration and hemorrhagic stroke; however, the statistical power was insufficient for this difference to be statistically significant. The effect of anemia on the risk of hemorrhagic stroke tended to be greater in female than male patients (P for interaction ¼ 0.11). A recent observational study demonstrated an association between anemia and a high incidence of composite stroke only in female patients [11] , suggesting a sex-based difference. Moreover, in the present study, the effect of anemia on the risk of hemorrhagic stroke tended to be greater in patients with a body weight of <53.8 kg than !53.8 kg (P for interaction ¼ 0.12). A combination of anemia and a lean body may indicate malnutrition, which has recently been recognized as a risk factor for atherosclerosis in patients undergoing HD [26] . Our results may indicate that female or lean patients with anemia are at higher risk of hemorrhagic stroke.
In our study, we did not identify a relationship between the hemoglobin concentration and the incidence of ischemic stroke. Some studies in the general population have suggested an association between high hemoglobin concentrations and the incidence of ischemic stroke [12, 27, 28] but not in patients with CKD, including those undergoing HD. In the TREAT study, the risk of stroke was increased in the group of patients with higher target hemoglobin concentrations treated by an ESA [4] . However, this previous study did not show which type of stroke was increased in patients with high hemoglobin concentrations. Moreover, there was no significant increase in stroke in other randomized controlled trials of patients using an The multivariable-adjusted model is adjusted for sex, dose of erythropoiesis-stimulating agent, serum phosphate concentration, Kt/V and systolic blood pressure, which were selected using the Cox proportional hazard model and a stepwise backward method with P < 0.05 for the remaining variables to determine the risk factors for the incidence of hemorrhagic stroke. Variables relevant to the subgroups are excluded from each model. Higher blood pressure is defined as systolic blood pressure of !140 mmHg or diastolic blood pressure of !90 mmHg. CI, confidence interval; DM, diabetes mellitus; ESA, erythropoiesis-stimulating agent; ESKD, end-stage kidney disease; HR, hazard ratio.
ESA [29] [30] [31] . Therefore, whether high hemoglobin concentrations are correlated with ischemic stroke in patients with CKD remains unclear. Intriguingly, our data obtained from the subgroup analysis suggested that higher hemoglobin concentrations were associated with a higher risk of ischemic stroke in patients who did not use antihypertensive drugs than in those who did use such drugs (P for interaction ¼ 0.04). This result is supported by the brain-protective effect of antihypertensive drugs [32, 33] . Moreover, the effect of high hemoglobin concentrations on the risk of ischemic stroke tended to be greater in patients with a CTR of <50% than !50%; however, the statistical power was insufficient for this finding to achieve statistical significance (P for interaction ¼ 0.11). The CTR reflects the volume status in patients undergoing HD [16] . A combination of a high hemoglobin concentration and low CTR appears to suggest hemoconcentration, which is a potential risk factor for ischemic stroke [5] . Well-conducted studies taking these points into consideration should be performed to elucidate whether high hemoglobin concentrations are indeed associated with ischemic stroke in patients undergoing HD.
A strength of our study is its large-scale, prospective design and wide-ranging inclusion criteria. Therefore, our results are generalizable to the real-world HD population. However, some limitations in our study should be noted. First, the hemoglobin concentrations were measured only at baseline. Second, measurement of baseline parameters might have been insufficient; e.g. data regarding the history of atrial fibrillation and the use of anticoagulants and antiplatelet drugs were missing. Third, physicians collected outcomes concerning stroke from the medical records, and these outcomes were not adjudicated by an independent committee for event evaluation. It is possible that some mild ischemic strokes were overlooked. In addition, a validation study on the completeness of the record-based data was not performed. Fourth, survival bias may have been present between patients undergoing prevalent and incident HD. Furthermore, previous studies have shown that high hemoglobin concentrations are associated with a risk of other cardiovascular events [4, [29] [30] [31] , leading to the recommendation that hemoglobin concentrations of patients undergoing HD should not exceed 12 g/dL in Japan [34] . Further, there may have been The multivariable-adjusted model is adjusted for age, cause of end-stage kidney disease, history of stroke and cardiothoracic ratio, which were selected using the Cox proportional hazard model and a stepwise backward method with P < 0.05 for the remaining variables to determine the risk factors for the incidence of ischemic stroke. Variables relevant to the subgroups are excluded from each model. Higher blood pressure is defined as systolic blood pressure of !140 mmHg or diastolic blood pressure of !90 mmHg. CI, confidence interval; DM, diabetes mellitus; ESA, erythropoiesis-stimulating agent; ESKD, end-stage kidney disease; HR, hazard ratio.
competing risks for mortality and cardiovascular (non-stroke) mortality. Further studies are required to address these limitations, which could not be resolved because of our study design.
In conclusion, our findings suggest that a low hemoglobin concentration is associated with a high risk of hemorrhagic stroke in patients undergoing HD but that there is no association between the hemoglobin concentration and the risk of ischemic stroke. These results may provide novel insights into the association between the hemoglobin concentration and stroke. Hemorrhagic stroke often has a more severe prognosis than ischemic stroke [35] . Therefore, further investigations are required to determine the optimal range of hemoglobin concentrations and appropriate therapy to maintain them within that range to prevent hemorrhagic stroke in patients undergoing maintenance HD.
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